Properties of immature and mature dendritic cells: phenotype, morphology, phagocytosis, and migration

被引:122
作者
Kim, Min Kyung [1 ]
Kim, Jaeyun [1 ,2 ,3 ]
机构
[1] Sungkyunkwan Univ SKKU, SAIHST, Dept Hlth Sci & Technol, Suwon 16419, South Korea
[2] Sungkyunkwan Univ SKKU, Sch Chem Engn, Suwon 16419, South Korea
[3] Sungkyunkwan Univ SKKU, Biomed Inst Convergence SKKU BICS, Suwon 16419, South Korea
基金
新加坡国家研究基金会;
关键词
IN-VIVO; ANTIGEN; ACTIVATION; MATURATION; IMMUNOTHERAPY;
D O I
10.1039/c9ra00818g
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Dendritic cells (DCs) are antigen-presenting cells that play an important role in connecting the innate and adaptive immunity of the immune system. To mediate innate and adaptive immunity, DCs pass through two stages: immature and mature. The change of phenotype is closely associated with the morphological and functional characteristics of DCs. Understanding these properties of DCs is important in the context of recent efforts on the developments of biomaterials-based cancer vaccine. In this paper, the morphological and phenotypical status of DCs in both stages were compared, and their relationship to the phagocytic and migratory ability of the cells was studied using bone-marrow derived dendritic cells (BMDCs). Immature DCs were of a circular shape and expressed low levels of costimulatory molecules, while mature DCs had longer dendrites and expressed high levels of costimulatory molecules. The phagocytic and migratory ability studied using the polymer bead uptake test and live imaging indicated that immature DCs have a pronounced phagocytic ability compared to mature DCs, while the mature DCs moves faster than immature DCs. These findings could be helpful for understanding the relationship between immature and mature DCs and analyzing initiation of the adaptive immune response by DCs in DC-mediated immunotherapy.
引用
收藏
页码:11230 / 11238
页数:9
相关论文
共 43 条
[1]   Manufacturing Cell Therapies Using Engineered Biomaterials [J].
Abdeen, Amr A. ;
Saha, Krishanu .
TRENDS IN BIOTECHNOLOGY, 2017, 35 (10) :971-982
[2]   Mammalian Toll-like receptors [J].
Akira, S .
CURRENT OPINION IN IMMUNOLOGY, 2003, 15 (01) :5-11
[3]  
Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
[4]   Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223) [J].
Andreae, S ;
Piras, F ;
Burdin, N ;
Triebel, F .
JOURNAL OF IMMUNOLOGY, 2002, 168 (08) :3874-3880
[5]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[6]   Dendritic cells with lymphocyte-stimulating activity differentiate from human CD133 positive precursors [J].
Bonetti, Maria Ida ;
Pieri, Laura ;
Domenici, Lola ;
Urbani, Serena ;
Romano, Giovanni ;
Aldinucci, Alessandra ;
Ballerini, Clara ;
Monici, Monica ;
Saccardi, Riccardo ;
Basile, Venere ;
Bosi, Alberto ;
Romagnoli, Paolo .
BLOOD, 2011, 117 (15) :3983-3995
[7]   Extra-Large Pore Mesoporous Silica Nanoparticles Enabling Co-Delivery of High Amounts of Protein Antigen and Toll-like Receptor 9 Agonist for Enhanced Cancer Vaccine Efficacy [J].
Cha, Bong Geun ;
Jeong, Ji Hoon ;
Kim, Jaeyun .
ACS CENTRAL SCIENCE, 2018, 4 (04) :484-492
[8]   Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane [J].
Chow, A ;
Toomre, D ;
Garrett, W ;
Mellman, I .
NATURE, 2002, 418 (6901) :988-994
[9]   Dendritic cells: a spot on sialic acid [J].
Crespo, Helio J. ;
Lau, Joseph T. Y. ;
Videira, Paula A. .
FRONTIERS IN IMMUNOLOGY, 2013, 4
[10]   Immature, semi-mature, and fully mature dendritic cells: toward a DC-cancer cells interface that augments anticancer immunity [J].
Dudek, Aleksandra M. ;
Martin, Shaun ;
Garg, Abhishek D. ;
Agostinis, Patrizia .
FRONTIERS IN IMMUNOLOGY, 2013, 4